Condensed Consolidated Statement of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-In Capital	Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2024		189,963,492
Beginning balance at Dec. 31, 2024	$ 97,366	$ 1,410,025	$ 82,048	$ (1,346,572)	$ (48,135)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	3,564		3,564
Issuance of common shares pursuant to exercise of options (in shares)		892,857
Issuance of common shares pursuant to ESPP	2,653	$ 4,616	(1,963)
Issuance of common shares pursuant to ESPP (in shares)		44,541
Issuance of common shares pursuant to ESPP	131	$ 173	(42)
Issuance of common shares upon vesting of RSUs		580,584
Issuance of common shares upon vesting of RSUs	0	$ 1,518	(1,518)
Unrealized loss on available-for-sale securities	(31)				(31)
Net income	(24,526)			(24,526)
Ending balance (in shares) at Mar. 31, 2025		191,481,474
Ending balance at Mar. 31, 2025	$ 79,157	$ 1,416,332	82,089	(1,371,098)	(48,166)
Beginning balance (in shares) at Dec. 31, 2025	192,531,225	192,531,225
Beginning balance at Dec. 31, 2025	$ 76,576	$ 1,421,429	83,318	(1,380,073)	(48,098)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	1,359		1,359
Issuance of common shares pursuant to exercise of options (in shares)		4,149,396
Issuance of common shares pursuant to ESPP	12,556	$ 22,262	(9,706)
Issuance of common shares pursuant to ESPP (in shares)		27,203
Issuance of common shares pursuant to ESPP	88	$ 115	(27)
Issuance of common shares upon vesting of RSUs		239,933
Issuance of common shares upon vesting of RSUs	0	$ 688	(688)
Unrealized loss on available-for-sale securities	(97)				(97)
Net income	$ 169,695			169,695
Ending balance (in shares) at Mar. 31, 2026	196,947,757	196,947,757
Ending balance at Mar. 31, 2026	$ 260,177	$ 1,444,494	$ 74,256	$ (1,210,378)	$ (48,195)